PRESS-RELEASE ·Filed Mar 20, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should monitor the upcoming earnings call on March 26 for any material financial disclosures or guidance updates, as this release provides no new data.
Final — all horizons settled through T+60d
DARE ▲ +45.59% at T+60d
NEUTRAL call +45.59% · α vs SPY +31.17% · entry $1.36 → $1.98
T+1d
+0.74%
call +0.74% · α -0.37%
$1.37
settled 7mo ago
T+5d
+13.97%
call +13.97% · α +16.12%
$1.55
settled 7mo ago
T+20d
+111.03%
call +111.03% · α +101.71%
$2.87
settled 6mo ago
T+60d
+45.59%
call +45.59% · α +31.17%
$1.98
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Daré Bioscience announced a conference call to discuss its financial results for the year ended December 31, 2025. The press release contains no actual financial data, only logistical details for the earnings call, with no material figures disclosed.
Key Facts
- Daré Bioscience will host an earnings call on March 26, 2026, to discuss 2025 financial results.
- No financial results or operational updates were included in the press release.
- The release serves only as an announcement for the upcoming call and webcast.
Financial Impact
No financial data provided
Risk Factors
- Lack of disclosed financials increases uncertainty ahead of the earnings call.
- Low market cap ($19M) suggests high volatility risk if results miss expectations.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259697 |
23 reports for DARE
71% Hit rate @ T+1 Went positive at some point 6 of 7 best @ T+60▲ +27.03%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
Showing 10 of 23
US Market Status
Market Open — Closes in 5h 14m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers